Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Wilate 500UI/500UI (Von Willebrand Factor, Coagulation Factor Viii In ...
FDA Approves Wilate for Hemophilia A in Adult and Adolescent Patients ...
FDA Expands Approval to wilate for Prophylaxis in All Types of VWDr
WILATE 500UI FA 5ML – Proasse
Wilate [von Willebrand Factor/Coagulation Factor VIII Complex (Human ...
FDA Expands Bleeding Prevention Use for Wilate - MPR
Wilate treatment for hemophilia | Hemophilia News Today
Wilate (antihemophilic and von Willebrand factors) - Drug Rx ...
DailyMed - WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII ...
Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human ...
What is the administration protocol for Wilate (von Willebrand factor)?
(PDF) Real-World Data on the Effectiveness and Safety of wilate for the ...
Wilate - Von Willebrand Factor/coagulati- NDC68982-182-01
Wilate 1000IU/1000IU (Von Willebrand Factor, Coagulation Factor Viii In ...
Wilate 1000UI/1000UI (Von Willebrand Factor, Coagulation Factor Viii In ...
Wilate Approved for Perioperative Management of Bleeding in VWD Patients
Hemostatic efficacy of Wilate using objective criteria | Download ...
Real-World Data on the Effectiveness and Safety of wilate for the ...
Wilate - Von Willebrand Factor/coagulation - NDC 67467-182
Wilate Approved for Routine Prophylaxis in Von Willebrand Disease ...
WILATE subst sèche 1000 IE avec solvant flac 1 pce | Commander en ligne
FDA Grants wilate Orphan Drug Exclusivity
WILATE (von Willebrand Factor/Coagulation Factor VIII Complex (Human ...
FDA approves Wilate for young children with von Willebrand disease
Wilate (Antihemophilic Factor/von Willebrand Factor Complex): Uses ...
Wilate - Liv Hospital
(PDF) Efficacy of Wilate Prophylaxis in Reducing Nosebleeds in Patients ...
WILATE - - Generic Name , Brand Names, How to use, Precautions, Side ...
Octapharma USA: FDA Grants Expanded Approval to wilate
Wilate 500 ui - Factor VIII de Coagulacion Sanguinea Humana - Farma Central
FDA Approves Wilate for Hemophilia A in Adult and Adolescent Patients - MPR
Wilate 500 ui - Factor VIII de Coagulacion Sanguinea Humana 500 ui ...
WILATE 1000UI FA 10ML – Proasse
wilate®
Dosing of von willebrand disease therapy
Octapharma USA: FDA Grants Expanded Approval to wilate® as the First ...
MPC - Home
These highlights do not include all the information needed to use ...
Lanzamiento Nuevo Producto “Wilate” - RRPGolden Integra Importadora S.A.
Take control of von willebrand disease (VWD)
Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement
Wilate, von Willebrand Factor/Coagulation Factor VIII Complex: Package ...
Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis ...
von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in ...
On demand treatment of von willebrand disease
Hemostatic management of von Willebrand disease during childbirth with ...
Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the ...
Medica RCP |Wilate 500IU | Indications | Side Effects | Composition ...
Prevent bleeding in surgery for people living with vwd
(PDF) Efficacy and safety of a VWF/FVIII concentrate (wilate ® ) in ...
RX ITEM-Wilate 1K 1K Unit Kit By ASD Healthcare
What is Wilate? • The Blood Project
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII ...
Wilate® Reconstitution Instructions - Octapharma
Prophylaxis of bleeding in von willebrand disease
Chokri Ben Lamine: Laboratory Findings and Management of Severe Type 3 ...
Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited ...
Hematoligical System Pharmacology.pptx
FDA Grants Expanded Approval to wilate® as the First VWF Concentrate ...
Clinical trial data in von willebrand disease
Efficacy and Safety of Prophylaxis With a Plasma‐Derived von Willebrand ...
Hospital Care - Al Inmaa
Factor VIII and von Willebrand factor activity levels during long-term ...
FDA Approves Octapharma’s WILATE® for Hemophilia A in Adult and ...
Wilate® – Infinitypharma
Wilate(凝血因子VIII复合物)获美国FDA批准用于6岁以下儿童血管性血友病预防 - 香港致泰药业